Gary Kahn

Gary Kahn currently serves as the Chief Corporate Development Officer at Salfarm, focusing on strategy, business development, licensing, M&A, and commercial operations since May 2025. Prior to this role, Gary Kahn spent nearly eleven years at Abacus Medicine Pharma Services, where positions included Vice President of Business Development and Director of Business Development, contributing to strategic commercialization programs for rare assets and spearheading a global expansion strategy. Gary Kahn also held various roles within Abacus Medicine, including Vice President of Business Development and Business Development Consultant. Academic qualifications include a Master of Science from Copenhagen Business School and a Bachelor of Arts in Anthropology from Grinnell College.